Abstract
Adriamycin is a potent chemotherapeutic agent used in the treatment of human neoplastic diseases. A major side effect limiting the use of this drug is its toxic effect on the heart. Several hypotheses have been proposed to explain the cardiotoxicity of Adriamycin. However, the most plausible hypothesis seems to be the reduction of Adriamycin and free radical production, which induces lipid peroxidation and oxidative damages in the heart.
We have thus undertaken this preliminary study to investigate Adriamycin-induced lipid peroxidation by the measurement of plasma thiobarbituric acid reactant materials and antioxidant systems, namely glutathione content, glutathione peroxidase activity, and vitamin and trace element status, in patients with cancer before and after chemotherapy, including Adriamycin.
The concentration of thiobarbituric acid reactant materials in plasma of patients with cancer was higher than in controls and was further increased after chemotherapy. Blood glutathione and plasma glutathione peroxidase activity, as well as plasma zinc and selenium in patients with cancer, were decreased, but not further modified by chemotherapy. However, only zinc and selenium levels reached a significant level. In contrast, plasma vitamin E and β-carotene levels were not significantly increased in patients with cancer. Finally, plasma vitamin A and copper levels were not modified either in patients with cancer or by chemotherapy.
Similar content being viewed by others
Abbreviations
- ADR:
-
Adriamycin
- GSH:
-
reduced glutathione
- GSSG:
-
oxidized glutathione
- GPx:
-
glutathione peroxidase
- OHP:
-
organic hydroperoxides
- TBARMs:
-
thiobarbituric acid reactant materials
References
R. C. Young, R. E. Ozols, and C. E. MeyersN. Engl. J. Med. 305, 139 (1981).
R. E. Ozols, R. C. Young, and J. L. SpeyerCancer Res. 42, 4265 (1982).
S. Ragajopalan, P. M. Politi, B. Sinha, and C. E. MeyersCancer Res. 48, 4766 (1988).
R. D. Olson, R. C. Boerth, J. G. Gerber, and A. S. NiesLife Sci. 29, 1393 (1981).
C. Winterbourn, G. F. Vile, and H. P. MonteiroFree Radic. Res. Commun. 12–13, 107 (1991).
K. Hermann, and S. HelmutExperientia 37, 1233 (1981).
K. Takahashi, T. Mayumi, and T. KishiChem. Pharm. Bull. 35, 4626 (1978).
J. C. Schisselbauer, M. Crescimanno, N. D’Alessandro, M. Clapper, S. Toulmond, H. Tapiero, and K. D. TewCancer Commun. 1, 133 (1989).
M. J. Richard, B. Portal, J. Meo, C. Coudray, A. Hadjian, and A. FavierClin. Chem. 38, 704 (1992).
R. L. Heath, and A. L. TappelAnal. Biochem. 76, 184 (1976).
W. A. Günzler, H. Kremers, and L. FloheZ. Klin. Chem. Klin. Biochem 10, 444 (1974).
T. P. M. Akerboom, and H. SiesMethods Enzymol. 77, 373 (1981).
J. Arnaud, S. Fortis, S. Blachier, D. Kia, and A. FavierJ. Chromatogr. 572, 103 (1991).
J. Arnaud, J. Bellanger, P. Chappuis, A. Favier, and M. GalliotAnn. Biol. Clin. 43, 297 (1985).
J. Arnaud, J. Bellanger, F. Bienvenu, P. Chappuis, and A. FavierAnn. Biol. Clin. 44, 77 (1986).
J. Arnaud, A. Prual, P. Preziosi, A. Favier, and S. HercbergJ. Trace Element Electrolytes Health Dis. 7, 199–204 (1993).
E. A. Lefrak, J. Pitha, S. Rosenheim, and J. A. GottliebCancer 32, 302 (1973).
R. A. Minow, R. S. Benjamin, and J. A. GottliebCancer Chemotherapy Rep. 6, 195 (1975).
S. NeidelProg. Med. Chem. 16, 151 (1979).
U. Montali, M. Del Tacca, C. Bernardini, D. Segnini, and G. Solaini,Drugs Explt. Clin. Res. 11, 219 (1985).
R. G. Canada, W. Saway, and E. ThompsonBiochem. Biophys. Res. Commun. 151, 679 (1988).
K. J. A. Davis, and J. H. DoroshowJ. Biol. Chem. 261, 3060 (1986).
H. NohlBiochem. Pharmacol. 37, 2633 (1988).
G. PowisFree Radical Biol. Med. 6, 63 (1989).
H. Hida, C. Coudray, J. Calop, and A. Favier,Biol Trace Element Res. accepted for publication (1994).
C. Coudray, S. Mouhiedine, M. J. Richard, J. Arnaud, J. de Leiris, and A. FavierBasic Res. Cardiol. 87, 173 (1992).
P. Sangeetha, U. N. Das, R. Koratkar, and P. SuriyaprabhaFree Radic Biol. Med. 8, 19 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Faber, M., Coudray, C., Hida, H. et al. Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including adriamycin. Biol Trace Elem Res 47, 117–123 (1995). https://doi.org/10.1007/BF02790108
Issue Date:
DOI: https://doi.org/10.1007/BF02790108